University of Virginia
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Virginia sits in the top decile of US sponsors by registered trial count (#78 of 15,742 sponsors by registered trial count).
University of Virginia: 449 sponsored US clinical trials, 101 recruiting.
University of Virginia sponsors 449 registered US clinical trials on ClinicalTrials.gov, 101 of them currently recruiting, and 281 completed. 40 of these trials are in Phase 3-4 (later-stage) and 109 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Type 1 Diabetes Mellitus, with 9 trials.
Top-decile sponsor footprint
University of Virginia ranks in the top decile of sponsors by registered trial count (#78 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
281 of 317 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
449 total, page 6 of 9
Treating Type 2 Diabetes by Reducing Postprandial Glucose Elevations: A Paradigm Shift in Lifestyle Modification
NCT03196895
Patient Perceptions and Willingness to Enroll in Clinical Trials
NCT03231852
Prenatal Consult With Illustrated Literature
NCT04267211
A Trial of Two Family-based Childhood Obesity Treatment Programs
NCT03245775
Standard Tubal Ligation Versus Salpingectomy for Sterilization at the Time of Cesarean Delivery
NCT03028623
Pilot Study to Investigate Contemplative Intervention in Lupus Patients
NCT03103243
Efficacy of inControl Advice: A Decision Support System (DSS) for Diabetes
NCT03093636
The Impact of Night Float on Anesthesiology Resident Sleep Patterns
NCT03325244
Evaluation of a Brief Tobacco Intervention in the US Military
NCT03196102
The Effect of Cryotherapy on Cerebral Hemodynamics Within Healthy Subjects
NCT03185507
Palpation and ACCURO for Placing Spinal in C-section
NCT03090295
Pilot Evaluation Comparing Regional Distribution of Ventilation During Lung Expansion Therapy
NCT03083379
Bathing Babies and Allergy
NCT03050658
Comparing the Effectiveness of Lung Expansion Therapy in Adult Human Subjects
NCT02892773
International Diabetes Closed Loop (iDCL) Trial: Research Site Training Protocol
NCT02844517
Pilot RCT of Pos4Health for Nonadherent HIV+ Substance Users
NCT02837250
Strategies to Promote Cessation in Smokers Who Are Not Ready To Quit
NCT02905656
Clinical Response to Rhinovirus Challenge
NCT02910401
Lung Fluid and Peripheral Blood Neutrophil IL-5 Surface Receptor in Children With Asthma
NCT02866487
Study of Genistein in Pediatric Oncology Patients (UVA-Gen001)
NCT02624388
Minimizing the Utilization of Voiding Cystourethrography for Patients With Antenatal Hydronephrosis
NCT02825485
HPV DNA Testing Through Mobile Mammography Unit
NCT03551028
Trial of Alvimopan in Major Spine Surgery
NCT02789111
Effect of Extra- Fine Versus Coarse-Particle Inhaled Corticosteroids (ICS) on Ventilation Heterogeneity in Children With Poorly Controlled Asthma
NCT02577497
Stereotactic Radiosurgery With Nivolumab and Valproate in Patients With Recurrent Glioblastoma
NCT02648633
New Technology to Assess Treatment for Chronic Obstructive Pulmonary Disease (COPD)
NCT02826343
Closed-Loop Control in Young Children 5-8 Years Old Using DiAs Platform
NCT02750267
Enduring Happiness and Continued Self-Enhancement
NCT02782611
Evaluating and Improving Functional Driving Vision of Patients With Astigmatism: Phase 3
NCT02950545
Web-based Interpretation Training For Anxiety
NCT02382003
Insulin-Glucose-Glucagon Network: Defining a Type 1 Diabetes Progression Index
NCT02663661
Prevention of Alcohol Related Incidents in the US Air Force
NCT01398319
Exercise Dosing Trial for Individuals With Parkinson's Disease
NCT02676804
Project Nightlight: Efficacy and System Acceptance of Dinner/Night vs. 24hr Closed Loop Control
NCT02679287
Handheld 3D Lumbar Spine Navigation: A Clinical Validation Study RM002
NCT02442973
Accuro Versus Traditional Landmark Palpation Technique to Determine Accurate Spinal Level for Procedures
NCT02862964
Established Status Epilepticus Treatment Trial
NCT01960075
The Impact of Fitness and Mineralocorticoid Receptor Blockade on Vascular Dysfunction in Adults With Type 1 Diabetes
NCT03174288
BGAT (Blood Glucose Awareness Training) for Users Who Might Become Pregnant
NCT02508779
Locally Applied Antibiotics for Infection Prophylaxis in Treatment of Open Fractures
NCT03705962
USS Virginia Closed-Loop Versus SAP Therapy for Hypoglycemia Reduction in T1D
NCT02302963
Enhancing the Efficacy of Smoking Quit Line in the Military (AFIII Renewal)
NCT02201810
HemoSonics-UVA HemoSonics-UVA Cardiac Surgery Clinical Study Protocol
NCT02456467
Tibial Tunnel Placement for ACL Reconstruction
NCT02374710
HemoSonics-UVA Spinal Surgery
NCT02418923
Development of a Comprehensive AP Training Curriculum for Adults
NCT02434094
Alanyl-glutamine Supplementation of Standard Treatment for C. Difficile Infection
NCT02053350
Rehabilitation With Patterned Electrical Neuromuscular Stimulation for Patients With Patellofemoral Pain
NCT02441712
Contraception and Alcohol Risk Reduction Internet Intervention Randomized Trial
NCT02128880
Single-dose Linaclotide for Capsule Endoscopy Preparation
NCT02465385
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 58 |
| Phase 2 | 51 |
| Phase 3 | 14 |
| Phase 4 | 26 |
Therapeutic Areas
What is open in the University of Virginia pipeline
101 recruiting of 449 indexed (22% open); 281 completed (63%).
Phase mix: 40 late (III/IV) vs 109 early (I/II) (early-phase heavy).
Top condition: Type 1 Diabetes Mellitus (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Virginia: open-pipeline peers nationwide
Peers matched on 449 registered trials and 22% open enrollment, not the therapeutic-area sidebar.
University of Virginia sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 449 trials (± recruiting share)
- Medical College of Wisconsin · 447 trials · 21% recruiting
- Alliance for Clinical Trials in Oncology · 446 trials · 7% recruiting
- Boston Children's Hospital · 462 trials · 24% recruiting
- Children's Hospital of Philadelphia · 431 trials · 18% recruiting
Sponsors near 22% open enrollment (± trial volume)
- Ohio State University Comprehensive Cancer Center · 23% recruiting · 341 trials
- University of Delaware · 23% recruiting · 106 trials
- University of Oklahoma · 22% recruiting · 358 trials
- ALX Oncology · 22% recruiting · 9 trials
Related
What to do with this University of Virginia page
449 registered trials is a research-attention snapshot, not an endorsement of University of Virginia or any single study.
- 101 of University of Virginia's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Type 1 Diabetes Mellitus is the condition University of Virginia studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Type 1 Diabetes Mellitus trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Virginia pipeline card: 449 registered trials from official public datasets.Report a data error.